Enveric Biosciences Inc.

NASDAQ: ENVB · Real-Time Price · USD
1.08
-0.03 (-2.70%)
At close: Aug 15, 2025, 3:57 PM
1.11
2.78%
After-hours: Aug 15, 2025, 04:38 PM EDT

Enveric Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
2.24M 2.29M 17.72M 17.36M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a -0.00 -0.00
Receivables
n/a 224.61K n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
n/a 567.6K 708.05K 380.84K
Total Current Assets
2.73M 3.58M 18.43M 17.74M
Property-Plant & Equipment
305.78K 507.38K 741.3K 470.73K
Goodwill & Intangibles
42.18K 210.93K 379.69K 8.51M
Total Long-Term Assets
347.96K 718.31K 1.12M 8.98M
Total Assets
3.08M 4.3M 19.55M 26.72M
Account Payables
521.75K 1.22M 463.27K 683.39K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a 63.82K 107.44K
Other Current Liabilities
3.09K 350.72K 1.7M -107.44K
Total Current Liabilities
1.49M 2.34M 4M 2.08M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a 653.67K
Total Long-Term Liabilities
n/a n/a 527.1K 2.33M
Total Liabilities
1.49M 2.34M 4M 4.41M
Total Debt
n/a n/a 63.82K 176.3K
Common Stock
6.78K 27.39K 20.78K 325.79K
Retained Earnings
-106.07M -96.5M -79.21M -60.74M
Comprehensive Income
-594.52K -569.75K -536.73K -30.8K
Shareholders Equity
1.59M 1.96M 14.67M 22.31M
Total Investments
n/a 1.82M n/a n/a